-
Entry Clinical Genomic Statement Genetic Variation (2.16.840.1.113883.10.20.20.2.1)
-
Entry Interpretive Phenotype Genetic Variation (2.16.840.1.113883.10.20.20.2.5.3)
-
Entry Interpretive Phenotype Pharmacogenomic Drug Efficacy (2.16.840.1.113883.10.20.20.2.5.4.1)
-
Entry Interpretive Phenotype Pharmacogenomic Drug Metabolism (2.16.840.1.113883.10.20.20.2.5.4.2)
-
Entry Genetic Variation Associated Observation Amino Acid Change Type (2.16.840.1.113883.10.20.20.2.1.1.1)
-
Entry Genetic Variation Associated Observation D N A Change Type (2.16.840.1.113883.10.20.20.2.1.2.1)
-
Entry Genetic Variation Associated Observation D N A Region Name (2.16.840.1.113883.10.20.20.2.1.3)
-
Entry Genetic Variation Associated Observation Zygosity (2.16.840.1.113883.10.20.20.2.1.4)
-
Entry Genetic Variation Associated Observation D N A Change Type (2.16.840.1.113883.10.20.20.2.1.2.1)
-
Entry Genetic Variation Associated Observation Amino Acid Change Type (2.16.840.1.113883.10.20.20.2.1.1.1)
-
Entry Genetic Variation Associated Observation Gene Identifier (2.16.840.1.113883.10.20.20.2.1.5)
-
Entry Genetic Variation Associated Observation Transcript Reference Sequence Identifier (2.16.840.1.113883.10.20.20.2.1.6)
-
Entry Genetic Variation Associated Observation D N A Sequence Variation Identifier (2.16.840.1.113883.10.20.20.2.1.7)
-
Entry Genetic Variation Associated Observation Genomic Reference Sequence Identifier (2.16.840.1.113883.10.20.20.2.1.8)
|